Ovarian cancer rates declining in breast cancer survivors
(HealthDay)—Primary ovarian cancer incidence is declining in the United States, both among the general population and among breast cancer survivors, according to research published online Jan. 2 in the ...
Cancer
Jan 08, 2013 |
not rated yet |
0
Specific protein essential for healthy eyes, study finds
Researchers at the Hebrew University of Jerusalem, in collaboration with researchers at the Salk Institute in California, have found for the first time that a specific protein is essential not only for maintaining a healthy ...
Neuroscience
Jan 07, 2013 |
5 / 5 (1) |
0
Why good resolutions about taking up a physical activity can be hard to keep
Physical inactivity is a major public health problem that has both social and neurobiological causes. According to the results of an Ipsos survey published on Monday 31 Dec., the French have put "taking up ...
Psychology & Psychiatry
Jan 04, 2013 |
4.5 / 5 (2) |
0
Dopamine-receptor gene variant linked to human longevity
(Medical Xpress)—A variant of a gene associated with active personality traits in humans seems to also be involved with living a longer life, UC Irvine and other researchers have found.
Neuroscience
Jan 03, 2013 |
3.7 / 5 (3) |
0
|
Telmisartan reverses insulin resistance in mice
(HealthDay)—Treating mice fed a high-fat diet with telmisartan reverses insulin resistance and glucose intolerance, but only when the peroxisome proliferator-activated receptor-δ (PPAR-δ) gene is present, ...
Diabetes
Jan 03, 2013 |
5 / 5 (1) |
0
|
Study shows naloxone kits cost-effective in preventing overdose deaths
(Medical Xpress)—Giving heroin users kits with the overdose antidote naloxone is a cost-effective way to prevent overdose deaths and save lives, according to a study released this week in The Annals of ...
Medications
Jan 02, 2013 |
not rated yet |
0
|
Researchers provide definitive proof for receptor's role in synapse development
Jackson Laboratory researchers led by Associate Professor Zhong-wei Zhang, Ph.D., have provided direct evidence that a specific neurotransmitter receptor is vital to the process of pruning synapses in the brains of newborn ...
Neuroscience
Dec 31, 2012 |
5 / 5 (2) |
0
|
Cholesterol boosts the memory of the immune system
The memory of the human immune system is critical for the development of vaccines. Only if the body recognizes a pathogen with which it has already come into contact in the case of a second infection, the ...
Immunology
Dec 24, 2012 |
5 / 5 (3) |
0
|
Targeting taste receptors in the gut may help fight obesity
Despite more than 25 years of research on antiobesity drugs, few medications have shown long-term success. Now researchers reporting online on December 21 in the Cell Press journal Trends in Endocrinology & Metabolism say th ...
Overweight and Obesity
Dec 21, 2012 |
5 / 5 (2) |
0
|
World-first tissue study could re-shape future of advanced prostate cancer treatment
The first-ever comprehensive study of prostate cancer tissue has revealed a completely new gene network driving the disease in patients who have stopped responding to standard hormone treatment, according ...
Cancer
Dec 21, 2012 |
not rated yet |
0
Healthy lifestyle during menopause may decrease breast cancer risk later on
Obese, postmenopausal women are at greater risk for developing breast cancer and their cancers tend to be more aggressive than those in lean counterparts. A University of Colorado Cancer Center study published in the December ...
Cancer
Dec 19, 2012 |
5 / 5 (1) |
0
Researchers discover a chemical that fends off harm to organs
(Medical Xpress)—Anesthesia is quite safe these days. But sometimes putting a patient under to fix one problem, such as heart damage, can harm a different organ, such as a kidney.
Medical research
Dec 18, 2012 |
5 / 5 (1) |
0
|
PR+ cells add prognostic value in luminal A breast cancer
(HealthDay)—Semiquantitative immunohistochemical expression of progesterone receptor-positive tumor cells improves prediction of survival within luminal A breast cancers, according to a study published ...
Cancer
Dec 17, 2012 |
not rated yet |
0
Ibrutinib has 'unprecedented' impact on mantle cell lymphoma
An international study of ibrutinib in people with relapsed or refractory mantle cell lymphoma (MCL) continues to show unprecedented and durable results with few side effects.
Cancer
Dec 14, 2012 |
not rated yet |
0
The HER2 paradox: HER2-positive stem cells found in HER2-negative breast cancer
A multicenter study led by researchers at UC Davis describes new, paradoxical characteristics of the most common type of breast cancer. The findings shed light on how the disease can evade treatment and could improve diagnosis ...
Cancer
Dec 14, 2012 |
5 / 5 (1) |
0
